Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (126)

Date

2021 (19)
2020 (55)
2019 (6)
2018 (34)
2017 (12)

Results for "[search-keyword]"

Search

Sponsor content

126 result(s) found, displaying 21 to 30

GlaxoSmithKline Consumer Healthcare Australia Pty Ltd - Compress, hot pack, chemical Cancelled under Section 41GL(d) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
GlaxoSmithKline Consumer Healthcare Australia Pty Ltd - Irrigation fluid, nasal Cancelled under Section 41GL(d) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
PANAFEN IB ibuprofen 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
BREVOXYL benzoyl peroxide 40mg/g Cream tube Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE nicotine 21mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE nicotine 7mg/24 hours transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE nicotine 14mg/24 hour transdermal drug delivery system sachet Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
OTRIVIN SINUS RELIEF tablets blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT nicotine 2mg lozenge blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd
NICABATE CQ MINT nicotine 4mg lozenge blister pack Cancelled under Section 30(1)(c) of the Act

17 December 2020

Cancellation by sponsor

Requested by GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Pages

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.